Ensayos clínicos

8.676 ensayos encontrados

Activo, no reclutaFase 2ClinicalTrials.gov

A Phase 2 Study to Assess the Efficacy and Safety of 2 Dosage Regimens of Oral Fidrisertib (IPN60130) for the Treatment of Fibrodysplasia Ossificans Progressiva in Male and Female Paediatric and Adult Participants.

INTERVENTIONALInicio: 1 de dic de 2021ID: NCT05039515

CompletadoFase 3ClinicalTrials.gov

A Phase III, Observer-Blind, Randomized, Multi-center Study to Evaluate the Safety, Tolerability, and Immunogenicity of Fluad and Agriflu Compared to the Non-adjuvanted Trivalent Influenza Vaccine Fluzone in Children 6 to < 72 Months of Age

INTERVENTIONALInicio: 1 de abr de 2011ID: NCT01346592

CompletadoFase 3ClinicalTrials.gov

A Randomized, Placebo-controlled Study to Evaluate the Effect of Tocilizumab on Disease Response in Patients With Active Systemic Juvenile Idiopathic Arthritis (JIA), With an Open-label Extension to Examine the Long Term Use of Tocilizumab

INTERVENTIONALInicio: 1 de may de 2008ID: NCT00642460

CompletadoFase 3ClinicalTrials.gov

A Randomized, Double-Blind, Placebo-Controlled Study Followed by an Open Label Treatment Period to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia

INTERVENTIONALInicio: 31 de may de 2018ID: NCT03510884

CompletadoFase 3ClinicalTrials.gov

A Randomised, Double-blind, Multi-centre Study to Evaluate the Efficacy and Safety of Inhaled Fluticasone Furoate in the Treatment of Persistent Asthma in Adults and Adolescents Currently Receiving Mid to High Strength Inhaled Corticosteroids.

INTERVENTIONALInicio: 1 de sept de 2011ID: NCT01431950

CompletadoFase 2ClinicalTrials.gov

Evaluation of the Pharmacokinetics, Safety, Tolerability and Efficacy of Entecavir (ETV) in Pediatric Subjects With Chronic Hepatitis B Virus (HBV) Infection Who Are HBeAg-Positive

INTERVENTIONALInicio: 30 de jun de 2007ID: NCT00423891

CompletadoFase 3ClinicalTrials.gov

Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of Ixekizumab in Patients From 6 to Less Than 18 Years of Age With Moderate-to-Severe Plaque Psoriasis

INTERVENTIONALInicio: 28 de mar de 2017ID: NCT03073200

CompletadoFase 3ClinicalTrials.gov

A Multicenter, Prospective, Open-label Study to Evaluate the Pharmacokinetics and Safety of Gadoquatrane in Pediatric Participants (From Birth to <18 Years) Undergoing Contrast-enhanced Magnetic Resonance Imaging (CE-MRI)

INTERVENTIONALInicio: 16 de ago de 2023ID: NCT05915026

CompletadoFase 3ClinicalTrials.gov

A Phase 3, Multicenter, Open-Label, Randomized, Comparator Controlled Trial of the Safety and Efficacy of Dalbavancin Versus Active Comparator in Pediatric Subjects With Acute Bacterial Skin and Skin Structure Infections

INTERVENTIONALInicio: 30 de mar de 2017ID: NCT02814916

ReclutandoFase 3ClinicalTrials.gov

A Phase 3 Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients From 1 Year to <18 Years of Age With Juvenile Idiopathic Arthritis (JIA)

INTERVENTIONALInicio: 5 de abr de 2019ID: NCT03773965

Activo, no reclutaFase 3ClinicalTrials.gov

A Phase 3, Multicenter, Multinational, Randomized, Double-blind, Double-dummy, Active-comparator Study to Evaluate the Efficacy and Safety of Venglustat in Adult and Pediatric Patients With Gaucher Disease Type 3 (GD3) Who Have Reached Therapeutic Goals With Enzyme Replacement Therapy (ERT)

INTERVENTIONALInicio: 18 de abr de 2022ID: NCT05222906

CompletadoFase 3ClinicalTrials.gov

Efficacy and Safety of Symbicort ®Turbuhaler® 160/4.5 µg/Inhalation, Two Inhalations Twice Daily Plus As-needed Compared With Seretide™ Diskus™ 50/500 µg/Inhalation, One Inhalation Twice Daily Plus Terbutaline Turbuhaler 0.4 mg/Inhalation As-needed - a 6-month, Randomised, Double-blind, Parallel-group, Active Controlled, Multinational Phase IIIB Study in Adult and Adolescent Patients With Persistent Asthma (AHEAD).

INTERVENTIONALInicio: 1 de may de 2005ID: NCT00242775

ReclutandoFase 3ClinicalTrials.gov

A Randomized, Double-blind, Double-dummy, Placebo-controlled, Multicenter, Phase 3 Study Assessing the Efficacy, Safety, and Tolerability of 2 Doses of Remibrutinib Over a 68-week Treatment Period in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE-2)

INTERVENTIONALInicio: 20 de mar de 2025ID: NCT06840392

ReclutandoFase 2ClinicalTrials.gov

A Phase 2, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Rademikibart as an Add-on Treatment for Acute Exacerbation in Adult and Adolescent Participants With Asthma and Type 2 Inflammation

INTERVENTIONALInicio: 8 de ago de 2025ID: NCT06940141

TerminadoFase 2ClinicalTrials.gov

A Pivotal Phase 1/2, Single-Arm, Open-label Study to Evaluate the Safety and Efficacy of Ponatinib With Chemotherapy in Pediatric Patients With Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Who Have Relapsed or Are Resistant or Intolerant to a Prior Tyrosine Kinase Inhibitor-Containing Therapy, or Who Have the T315I Mutation

INTERVENTIONALInicio: 24 de feb de 2021ID: NCT04501614

CompletadoFase 3ClinicalTrials.gov

Multicenter, Open-label, Active-controlled, Randomized Study to Evaluate the Efficacy and Safety of an age-and Body Weight-adjusted Rivaroxaban Regimen Compared to Standard of Care in Children With Acute Venous Thromboembolism

INTERVENTIONALInicio: 13 de nov de 2014ID: NCT02234843

CompletadoClinicalTrials.gov

A Prospective, Longitudinal, Observational Study to Evaluate Neurodevelopmental Status in Pediatric Patients With Hunter Syndrome (MPS II)

OBSERVATIONALInicio: 18 de ene de 2013ID: NCT01822184

ReclutandoFase 2ClinicalTrials.gov

An Open-Label Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder

INTERVENTIONALInicio: 3 de jul de 2023ID: NCT05549258

ReclutandoFase 3ClinicalTrials.gov

A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Investigate the Efficacy, Safety, and PK/ PD of Finerenone, in Addition to Standard-of-care, in Pediatric Patients, 6 Months to < 18 Years of Age With Heart Failure (HF) and Left Ventricular Systolic Dysfunction (LVSD)

INTERVENTIONALInicio: 19 de nov de 2025ID: NCT07188805

Activo, no reclutaFase 3ClinicalTrials.gov

A Phase 3 Multicenter, Open-label Study to Evaluate the Efficacy, Pharmacokinetics, Safety, and Immunogenicity of Subcutaneously Administered Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis (PSUMMIT-Jr)

INTERVENTIONALInicio: 30 de ago de 2022ID: NCT05083182